IMMUTEP LIMITED - AMER
2,0306
08-октября-24 10:43:48
15 мин. задержка
Акции
-0,0194
-0,95%
Сегодняшний диапазон
2,0200 - 2,0500
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
29 окт 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report & Appendix 4C
28 окт 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
Immutep to Present Phase II TACTI-002 Data at SITC 2021
01 окт 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
Immutep Receives A$3.4 million R&D Tax Incentive from French Government
29 сен 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Immutep to Present at Healthcare Investor Conferences
28 сен 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
21 сен 2021 07:38:03 Источник Nasdaq GlobeNewswire
-
Immutep Completes Recruitment of 2nd line PD-1/PD-L1 refractory NSCLC Patients in TACTI-002
01 сен 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Immutep’s Chinese Partner, Eoc Pharma, Expands Efti Trial Pipeline
31 авг 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Immutep Announces Chinese Patent Grant for LAG-3 Antagonist Antibody LAG525
27 авг 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
05 авг 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
13 июл 2021 07:00:03 Источник Nasdaq GlobeNewswire
-
Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC
06 июл 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
21 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
21 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Immutep Reveals a New Anti-LAG-3 Research Program
08 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Immutep Reports Positive Data from its TACTI-002 Phase II Study of LAG-3 Therapy, Efti, at ASCO 2021
04 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
04 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
02 июн 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
Immutep Enters Into A New Collaboration With Merck KGaA, Darmstadt, Germany For LAG-3 Therapy, Efti
01 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Immutep Granted Chinese Patent For Eftilagimod Alpha In Chemo-Immunotherapy Combination
26 май 2021 07:00:01 Источник Nasdaq GlobeNewswire